Tema Heart & Health ETF (HRTS)
NASDAQ: HRTS · Real-Time Price · USD
34.78
0.00 (0.00%)
Mar 10, 2026, 4:00 PM EDT - Market open
HRTS Holdings Information
HRTS is an equity ETF with a total of 45 individual holdings. The top holdings are Eli Lilly and Company stock at 9.95%, Roche Holding AG at 5.36%, Johnson & Johnson at 4.96%, AstraZeneca at 4.71%, and Merck & Co. at 4.18%.
Total Holdings
45
Top 10 Percentage
47.79%
Asset Class
Equity
ETF Category
Health
Assets
53.16M
PE Ratio
23.27
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 9.95% |
| 2 | RHHBY | Roche Holding AG | 5.36% |
| 3 | JNJ | Johnson & Johnson | 4.96% |
| 4 | LON: AZN | AstraZeneca PLC | 4.71% |
| 5 | MRK | Merck & Co., Inc. | 4.18% |
| 6 | TMO | Thermo Fisher Scientific Inc. | 4.06% |
| 7 | UNH | UnitedHealth Group Incorporated | 3.97% |
| 8 | GILD | Gilead Sciences, Inc. | 3.69% |
| 9 | SWX: NOVN | Novartis AG | 3.57% |
| 10 | ABT | Abbott Laboratories | 3.35% |
| 11 | VRTX | Vertex Pharmaceuticals Incorporated | 3.26% |
| 12 | ABBV | AbbVie Inc. | 3.09% |
| 13 | DHR | Danaher Corporation | 2.86% |
| 14 | CPH: NOVO.B | Novo Nordisk A/S | 2.32% |
| 15 | MDT | Medtronic plc | 2.32% |
| 16 | BBIO | BridgeBio Pharma, Inc. | 2.32% |
| 17 | RVMD | Revolution Medicines, Inc. | 2.25% |
| 18 | BMY | Bristol-Myers Squibb Company | 2.21% |
| 19 | MCK | McKesson Corporation | 2.12% |
| 20 | BSX | Boston Scientific Corporation | 2.11% |
| 21 | AMGN | Amgen Inc. | 2.10% |
| 22 | REGN | Regeneron Pharmaceuticals, Inc. | 2.07% |
| 23 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 1.97% |
| 24 | EW | Edwards Lifesciences Corporation | 1.85% |
| 25 | TEVA | Teva Pharmaceutical Industries Limited | 1.56% |
As of Mar 6, 2026